
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Immunol. , 07 March 2025
Sec. Systems Immunology
Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1572273
This article is a correction to:
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
A Corrigendum on
Differential co-expression network analysis reveals key hub-high traffic genes as potential therapeutic targets for COVID-19 pandemic
By Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP and Barkema HW (2021) Front. Immunol. 12:789317. doi: 10.3389/fimmu.2021.789317
In the published article, there was an error in affiliation 2. Instead of “Biomedical Center for Systems Biology Science Munich, Ludwig-Maximilians-University, Munich, Germany”, it should be “Nuclear Agriculture Research School, Nuclear Science and Technology Research Institute, Karaj, Iran”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: systems biology, systems immunology, WGCNA, hub-high traffic genes, immunopathogenesis, therapeutic targets in infectious diseases, COVID-19 pandemic
Citation: Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP and Barkema HW (2025) Corrigendum: Differential co-expression network analysis reveals key hub-high traffic genes as potential therapeutic targets for COVID-19 pandemic. Front. Immunol. 16:1572273. doi: 10.3389/fimmu.2025.1572273
Received: 06 February 2025; Accepted: 12 February 2025;
Published: 07 March 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Hasankhani, Bahrami, Sheybani, Aria, Hemati, Fatehi, Ghaem Maghami Farahani, Javanmard, Rezaee, Kastelic and Barkema. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Aliakbar Hasankhani, QS5oYXNhbmtoYW5pNzRAdXQuYWMuaXI=; Abolfazl Bahrami, QS5CYWhyYW1pQHV0LmFjLmly
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.